UK Markets closed

Southeast Asia Lip Cold Sore Treatment Market Report 2021: Revenue Estimation and Forecast to 2030 - Demand for Patches Burgeoning

·5-min read

Dublin, Aug. 26, 2021 (GLOBE NEWSWIRE) -- The "Lip Cold Sore Treatment Market in China, South Korea, Taiwan, Hong Kong, and Southeast Asia -Revenue Estimation and Forecast by 2030" report has been added to ResearchAndMarkets.com's offering.

China and SEA lip cold sore treatment market size is set to increase to $85,265.1 thousand in 2030 from $45,262.1 thousand in 2020, at a 6.7% CAGR between 2021 and 2030.

In China and Southeast Asia (SEA), the prevalence of herpes simplex virus type-1 (HSV-1) infection is increasing. Mostly transmitted via mouth-mouth contact, the infection often presents with no symptoms, which makes infected people a potential carrier without their knowledge.

HSV-1 infection most commonly presents on and around the lips as blisters. The most-prominent symptoms of this infection are painful gums, headache, fever, swollen lymph nodes, muscle ache, and sore throat. Apart from being in contact with infected people, fatigue, abnormal hormone levels, physical trauma, physiological and psychological stress, and immunosuppression greatly elevate the risk of HSV-1. Thus, the China and SEA lip cold sore treatment market is growing with the rising demand for products that can offer symptomatic relief and speed up the healing of the sores.

The containment measures taken in the wake of the COVID-19 pandemic have led to the shutting down of factories and reduced trade of an array of products. As a result, the China and SEA lip cold sore treatment market was negatively affected due to the curtailed manufacturing activities and people staying home. Moreover, the widespread financial distress has forced people to spend only on essential stuff, such as important medication and ration.

The fastest growth in the China and SEA lip cold sore treatment market in the coming years will be seen in the cream category, on the basis of product type. Creams not only relieve itching, pain, tingling, and burning sensations but also inhibit the growth of the virus.

Throughout this decade, the clinics category is projected to hold the largest share in the China and SEA lip cold sore treatment market, based on end user. An increasing number of people suffering from this condition are visiting clinics due to the rising awareness on this disease.

The pharmacies category dominated the China and SEA lip cold sore treatment market in the past, under segmentation by distribution channel. In most cases, a dermatologist prescribes the treatment for this condition, which is why the products are bought predominantly from pharmacies.

The SEA lip cold sore treatment market has been the most productive in China till now, and this country is also set to witness the highest CAGR in the years to come. With the increasing prevalence of HSV-1 infection in rural China and the increasing awareness on this disease, the demand for the related treatment products is rising in the country.

Key Findings of China and SEA Lip Cold Sore Treatment Market

  • Increasing HSV-1 infection incidence strongest market growth driver

  • Demand for patches for lip cold sore treatment burgeoning

  • Highest consumption of lip cold sore treatment products seen in clinics

  • Pharmacies continue being preferred sales point

  • Market fragmented in nature

  • Players engaging in mergers and acquisitions for larger market share

The most-significant players in the China and SEA lip cold sore treatment market include

  • Perrigo Company plc

  • Church & Dwight Co. Inc.

  • Kyungdong Pharmaceutical Co. Ltd.

  • Quantum Health

  • Carma Labs Inc.

  • Integria Healthcare (Australia) Pty Ltd

  • Blistex Inc.

  • Alliance Pharma plc

  • Li & Fung Limited

  • Viatris Inc.

  • GlaxoSmithKline plc

  • URGO Group

  • Laboratoire HRA Pharma SAS

Key Topics Covered:

Chapter 1. Research Background

Chapter 2. Research Methodology

Chapter 3. Executive Summary

Chapter 4. Introduction
4.1 Definition of Market Segments
4.1.1 By Product Type
4.1.1.1 Cream
4.1.1.2 Patch
4.1.1.3 Gel
4.1.1.4 Others
4.1.2 By End User
4.1.2.1 Clinics
4.1.2.2 Hospitals
4.1.2.3 Homecare settings
4.1.3 By Distribution Channel
4.1.3.1 Pharmacies
4.1.3.2 E-commerce
4.1.3.3 Direct sales
4.1.3.4 Grocery stores
4.2 Market Dynamics
4.2.1 Trends
4.2.1.1 Increasing demand for patches
4.2.2 Drivers
4.2.2.1 Proliferating modes of transmission of herpes simplex virus
4.2.2.2 Increasing prevalence of cold sores
4.2.2.3 Advancements in treatment with rising number of product launches
4.2.2.4 High lip core sore incidence among children
4.2.2.5 Impact analysis of drivers on market forecast
4.2.3 Restraints
4.2.3.1 Side-effects of lip cold sore treatment products
4.2.3.2 Lack of awareness on lip cold sores and HSV-1 infection
4.2.3.3 Impact analysis of restraints on market forecast
4.2.4 Opportunities
4.2.4.1 Growing disposable personal income
4.3 COVID-19 Impact
4.4 Porter's Five Forces Analysis
4.4.1 Bargaining Power of Buyers
4.4.2 Bargaining Power of Suppliers
4.4.3 Intensity of Rivalry
4.4.4 Threat of New Entrants
4.4.5 Threat of Substitutes

Chapter 5. China, South Korea, Taiwan, Hong Kong, and SEA Market Size and Forecast
5.1 Overview
5.2 Market Revenue, by Product Type (2015-2030)
5.3 Market Revenue, by End User (2015-2030)
5.4 Market Revenue, by Distribution Channel (2015-2030)
5.5 Market Revenue, by Country (2015-2030)

Chapter 6. China Market Size and Forecast

Chapter 7. Indonesia Market Size and Forecast

Chapter 8. Philippines Market Size and Forecast

Chapter 9. Vietnam Market Size and Forecast

Chapter 10. Thailand Market Size and Forecast

Chapter 11. South Korea Market Size and Forecast

Chapter 12. Malaysia Market Size and Forecast

Chapter 13. Taiwan Market Size and Forecast

Chapter 14. Hong Kong Market Size and Forecast

Chapter 15. Competitive Landscape

Chapter 16. Company Profiles
16.1 Business Overview
16.2 Product and Service Offerings
16.3 Key Financial Summary

For more information about this report visit https://www.researchandmarkets.com/r/njvx9e

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting